François Premel-Cabic

François Premel-Cabic is a professional in Venture Capital focusing on HealthTech at BNP Paribas since January 2020, where notable achievements include supporting six new startups and managing a portfolio of 14 companies. In addition to this role, François serves as a Board Observer at NaoX Technologies and a Board Guest at Mila. Prior experience includes a position as a Venture Capital Analyst for Life Sciences at Omnes Capital, where responsibilities encompassed opportunity sourcing and strategic analysis. François also held various internships in pharmaceutical settings, including roles at CHU de Rennes and Servier, and possesses advanced education in Biopharmaceutical Management from ESCP Business School and a PharmD from Université de Rennes I.